Our Services

The Endobronchial and Surgical Lung Volume Reduction Center

Lung Volume Reduction Surgery
© 2019 Nature In Human Health

The Center for Chest Disease and Respiratory Failure at New York-Presbyterian/Columbia University Irving Medical Center is a state-of-the-art facility for the diagnosis and treatment of pulmonary disease. The Center has earned a reputation for the depth of its clinical expertise and rigorous commitment to excellence. Experts in every medical and surgical specialty relating to advance lung disease participate in this program to provide multi-disciplinary patient care.

Lung Volume Reduction Surgery (LVRS) is an operation to remove the most damaged parts of both lungs.The damaged lung tissue is removed through a minimally invasive VATS (video-assisted thoracoscopic surgery) procedure. This method uses three to five small incisions to allow the surgeon to insert specially designed instruments between the ribs and into the chest to remove up to 25 to 30 percent of the most damaged areas of the lung. By removing the non-functioning damaged areas of the lung, air will move in and out of the remaining lung more easily and improve overall lung function.

Our program is one of the nation’s most experienced LVRS programs and participated in thelandmark NationalEmphysema Treatment Trial (NETT).The NETT study demonstrated that in carefully selected patients the procedure can improve quality of life, exercise capacity, lung function, and even survival. New York-Presbyterian/ColumbiaUniversity Irving Medical Center is the only New York City-area hospital — and one of only a small numbers of centers nationwide — to be selected by the Centers for Medicare & Medicaid Services (CMS) as a Center of Excellence to perform this procedure. Since the completion of the NETT, our

Lung Volume Reduction Surgery improves survival rates.
© 2019 Nature In Human Health

center has performed over 120 LVRS procedures with excellent patient outcomes including a one-year postoperative survival/mortality rate of 99 percent, far better than the previously reported national average. The key to our success is careful patient selection and an experienced team.

The Lung Volume Reduction Program has participated in several studies involving new minimally invasive treatmentoptions. The newest FDA approved device, the Zephyr valve, allows for endoscopic lung volume reduction.The valve is placed by bronchoscope which is a flexible thin tube with a tiny camera that passes through your mouth, down your throat, and into your lungs. It uses a valve to block off the most damaged parts of the lung so the healthier areas can function more efficiently. This latest procedure provides analternative for some patients to surgery.

The New York Presbyterian/Columbia Difference

New York Presbyterian/Columbia University Irving Medical Center is unique because we can tailor care and develop an individual plan of care to optimize each patient’s outcomes. We offer the most comprehensive medical and surgical treatments which may include medication recommendations, pulmonary rehabilitation, LVRS, Zephyr valve procedure, or a referral to the lung transplant program. The purpose of both the surgery and valves is to reduce shortness of breath, improve lung function and improve quality of life. To determine which treatment is best, we will schedule you for the following tests:

Lung Volume Reduction using Endobronchial Valves
2014 Pulmonx

  • High-resolution chest CT scan without contrast
  • Quantitative pulmonary perfusion scintigraphy
  • Chest X-ray
  • Electrocardiogram (EKG)
  • Echocardiogram (ECHO)
  • Pulmonary function tests including arterial blood gas
  • Six-minute walk
  • Cardiopulmonary exercise test
  • Nurse Coordinator consultation
  • Pulmonologist consultation

Endobronchial Valves
2014 Pulmonx

A multidisciplinary team meeting occurs twice a month where the patient’s clinical histories, lung function, and imaging are reviewed. The team is comprised of experienced pulmonologists, thoracic surgeons, radiologist, nurses, and interventional bronchoscopy specialists. All patients discussed are evaluated for their eligibility for Zephyr Endobronchial Valve therapy, LVRS or referral to lung transplant.

We are committed to working closely with all referring physicians and believe that ongoing communication is essential to optimal patient care. To start the evaluation process, please send a copy of your insurance cards both front and back along with the questionnaire via fax, email or mail. We will then contact you to schedule the necessary appointments. Please feel free to call 212-305-1158 fax 212-305-0412 or email [email protected] to communicate directly with a staff member.

The Endobronchial and Surgical Lung Volume Reduction Center NewYork-Presbyterian/Columbia